Evidence map›Paper›PMID 25901322›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Dynamic regulation of innate immune responses in Drosophila by Senju-mediated glycosylation.

Miki Yamamoto-Hino, Masatoshi Muraoka, Shu Kondo, Ryu Ueda, Hideyuki Okano, Satoshi Goto

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. International journal of molecular sciences · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. GlycoMineScientific reports · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Miki Yamamoto-HinoDepartment of Life Science, Rikkyo University, Tokyo 171-8501, Japan;
Masatoshi MuraokaStem Cell Project Group, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan;
Shu KondoInvertebrate Genetics Laboratory, Genetic Strains Research Center, National Institute of Genetics, Mishima 411-8540, Japan; and.
Ryu UedaInvertebrate Genetics Laboratory, Genetic Strains Research Center, National Institute of Genetics, Mishima 411-8540, Japan; and.
Hideyuki OkanoDepartment of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Satoshi GotoDepartment of Life Science, Rikkyo University, Tokyo 171-8501, Japan; Department of Physiology, Keio University School of Medicine, Tokyo 160-8582, Japan stgoto@rikkyo.ac.jp.
Keio University · JPNational Institute of Genetics · JPRikkyo University · JPTokyo Metropolitan Institute of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The innate immune system is the first line of defense encountered by invading pathogens. Delayed and/or inadequate innate immune responses can result in failure to combat pathogens, whereas excessive and/or inappropriate responses cause runaway inflammation. Therefore, immune responses are tightly regulated from initiation to resolution and are repressed during the steady state. It is well known that glycans presented on pathogens play important roles in pathogen recognition and the interactions between host molecules and microbes; however, the function of glycans of host organisms in innate immune responses is less well known. Here, we show that innate immune quiescence and strength of the immune response are controlled by host glycosylation involving a novel UDP-galactose transporter called Senju. In senju mutants, reduced expression of galactose-containing glycans resulted in hyperactivation of the Toll signaling pathway in the absence of immune challenges. Genetic epistasis and biochemical analyses revealed that Senju regulates the Toll signaling pathway at a step that converts Toll ligand Spatzle to its active form. Interestingly, Toll activation in immune-challenged wild type (WT) flies reduced the expression of galactose-containing glycans. Suppression of the degalactosylation by senju overexpression resulted in reduced induction of Toll-dependent expression of an antimicrobial peptide, Drosomycin, and increased susceptibility to infection with Gram-positive bacteria. These data suggest that Senju-mediated galactosylation suppresses undesirable Toll signaling activation during the steady state; however, Toll activation in response to infection leads to degalactosylation, which raises the immune response to an adequate level and contributes to the prompt elimination of pathogens.

Indexed as

GlycosylationImmunity, InnateAnimalsAnimals, Genetically ModifiedDrosophila melanogasterDrosophila ProteinsEpistasis, GeneticGalactoseImmune SystemLectinsMonosaccharide Transport ProteinsMutationPolysaccharidesRecombination, GeneticToll-Like ReceptorsUDP-Galactose TranslocatorsDrosophila ProteinsGalactoseLectinsMonosaccharide Transport ProteinsPolysaccharidesSenju protein, DrosophilaTl protein, DrosophilaToll-Like ReceptorsUDP-Galactose Translocatorsgalactoseglycosylationinnate immunitynucleotide sugar transporterToll pathway

Identifiers

PMID25901322
PMCPMC4426399
OpenAlexW2030956358

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.